Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Female infertility due to zona pellucida defect is a rare, genetic, female infertility disorder characterized by the presence of abnormal oocytes that lack a zona pellucida. Affected individuals are unable to conceive despite having normal menstrual cycles and sex hormone levels, as well as no obstructions in the fallopian tubes or defects of the uterus or adnexa.
Features include always present findings: Female infertility and Absent zona pellucida.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Hormones | 1 | Female infertility |
ZP1 function has not been fully characterized.
Female infertility due to zona pellucida defect is associated with mutations in the ZP1 gene on chromosome 11.
Genetic testing for ZP1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for female infertility due to zona pellucida defect.
119 publications have been identified in PubMed for female infertility due to zona pellucida defect. Kisho has analyzed 28 by research type. Research spans Basic Science / Preclinical (46%), Review / Meta-Analysis (29%), and Case Report / Case Series (7%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 13 | 46% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 12:18 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
8 |
29% |
Patient case studies | 2 | 7% |
Disease patterns and progression | 2 | 7% |
New treatment approaches | 2 | 7% |
Clinical study results | 1 | 4% |
Chen B (2026). [PMID: 41005306](https://pubmed.ncbi.nlm.nih.gov/41005306/). *Cell Genom*. [Basic Science / Preclinical]
Liang S (2026). [PMID: 42009647](https://pubmed.ncbi.nlm.nih.gov/42009647/). *Cell Death Discov*. [Basic Science / Preclinical]
Lord M (2026). [PMID: 28613709](https://pubmed.ncbi.nlm.nih.gov/28613709/). *Unknown Journal*. [Basic Science / Preclinical]
Yu L (2026). [PMID: 42063164](https://pubmed.ncbi.nlm.nih.gov/42063164/). *J Ovarian Res*. [Basic Science / Preclinical]
Mashiko D (2026). [PMID: 41263505](https://pubmed.ncbi.nlm.nih.gov/41263505/). *Biol Reprod*. [Basic Science / Preclinical]
Hart HM (2025). [PMID: 40698010](https://pubmed.ncbi.nlm.nih.gov/40698010/). *Hum Reprod Open*. [Review / Meta-Analysis]
Noda T (2025). [PMID: 40962834](https://pubmed.ncbi.nlm.nih.gov/40962834/). *Nat Commun*. [Basic Science / Preclinical]
Esbert M (2025). [PMID: 39786528](https://pubmed.ncbi.nlm.nih.gov/39786528/). *J Assist Reprod Genet*. [Basic Science / Preclinical]
Adnane M (2025). [PMID: 39572916](https://pubmed.ncbi.nlm.nih.gov/39572916/). *Curr Mol Med*. [Review / Meta-Analysis]
Rajput N (2025). [PMID: 40902255](https://pubmed.ncbi.nlm.nih.gov/40902255/). *Mutat Res Rev Mutat Res*. [Review / Meta-Analysis]